Form 4 for TNXP Tonix Pharmaceuticals Holding Corp.
Accepted 2021-09-28 00:00:00 ET · period of report 2021-09-28 · accession 0001387131-21-009696 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-28 | 2021-09-28 | TNXP | LEDERMAN SETH | CEO, Dir | P - Purchase | $0.61 | +12.0K | 12.2K | +6,780% | +$7,320 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.001 par value | 2021-09-28 | P | A | 12,000 | $0.61 | 12,177 | D | — | — |